Around half of the breast cancer tissue specimens (52.8%, 210/398) expressed high METTL14 expression, compared with 75.0% (18/24) of normal breast tissue specimens (Figure 2); the between-group difference was significant (P = 0.034) (Table 1). The gene discussed is METTL14; the disease is breast carcinoma.